- •Contents
- •General Introduction
- •Objectives
- •1 Introduction to Glaucoma: Terminology, Epidemiology, and Heredity
- •Definitions
- •Classification
- •Open-Angle, Angle-Closure, Primary, and Secondary Glaucomas
- •Combined-Mechanism Glaucoma
- •Epidemiologic Aspects of Glaucoma
- •Primary Open-Angle Glaucoma
- •Primary Angle-Closure Glaucoma
- •Genetics, Environmental Factors, and Glaucoma
- •Environmental Factors
- •Genetic Testing
- •Aqueous Humor Formation
- •Suppression of Aqueous Formation
- •Rate of Aqueous Formation
- •Aqueous Humor Outflow
- •Trabecular Outflow
- •Uveoscleral Outflow
- •Tonography
- •Episcleral Venous Pressure
- •Intraocular Pressure
- •Distribution in the Population and Relation to Glaucoma
- •Factors Influencing Intraocular Pressure
- •Diurnal Variation
- •Clinical Measurement of Intraocular Pressure
- •Infection Control in Clinical Tonometry
- •3 Clinical Evaluation
- •History and General Examination
- •Refraction
- •External Adnexae
- •Pupils
- •Biomicroscopy
- •Gonioscopy
- •Direct and Indirect Gonioscopy
- •Gonioscopic Assessment and Documentation
- •The Optic Nerve
- •Anatomy and Pathology
- •Glaucomatous Optic Neuropathy
- •Examination of the Optic Nerve Head
- •The Visual Field
- •Clinical Perimetry
- •Variables in Perimetry
- •Automated Static Perimetry
- •Interpretation of a Single Visual Field
- •Interpretation of a Series of Visual Fields
- •Patterns of Glaucomatous Nerve Loss
- •Manual Perimetry
- •Other Tests
- •4 Open-Angle Glaucoma
- •Primary Open-Angle Glaucoma
- •Clinical Features
- •Risk Factors for POAG Other Than IOP
- •Associated Disorders
- •Prognosis
- •Clinical Features
- •Differential Diagnosis
- •Diagnostic Evaluation
- •Prognosis and Therapy
- •The Glaucoma Suspect
- •Ocular Hypertension
- •Secondary Open-Angle Glaucoma
- •Exfoliation Syndrome
- •Pigmentary Glaucoma
- •Lens-Induced Glaucoma
- •Intraocular Tumors
- •Ocular Inflammation and Secondary Glaucoma
- •Elevated Episcleral Venous Pressure
- •Accidental and Surgical Trauma
- •Schwartz Syndrome (Schwartz-Matsuo Syndrome)
- •Drugs and Glaucoma
- •5 Angle-Closure Glaucoma
- •Introduction
- •Pathogenesis and Pathophysiology of Angle Closure
- •Pupillary Block
- •Angle Closure Without Pupillary Block
- •Lens-Induced Angle-Closure Glaucoma
- •Iris-Induced Angle Closure
- •Primary Angle Closure
- •Risk Factors for Developing Primary Angle Closure
- •Acute Primary Angle Closure
- •Subacute or Intermittent Angle Closure
- •Chronic Angle Closure
- •The Occludable, or Narrow, Anterior Chamber Angle
- •Plateau Iris
- •Secondary Angle Closure With Pupillary Block
- •Lens-Induced Angle Closure
- •Secondary Angle Closure Without Pupillary Block
- •Neovascular Glaucoma
- •Iridocorneal Endothelial Syndrome
- •Tumors
- •Inflammation
- •Aqueous Misdirection
- •Nonrhegmatogenous Retinal Detachment and Uveal Effusions
- •Epithelial and Fibrous Ingrowth
- •Trauma
- •Retinal Surgery and Retinal Vascular Disease
- •Nanophthalmos
- •Persistent Fetal Vasculature
- •Flat Anterior Chamber
- •Drug-Induced Secondary Angle-Closure Glaucoma
- •6 Childhood Glaucoma
- •Classification
- •Genetics
- •Primary Congenital Glaucoma
- •Juvenile Open-Angle Glaucoma
- •Developmental Glaucomas of Childhood With Associated Ocular or Systemic Anomalies
- •Axenfeld-Rieger Syndrome
- •Peters Anomaly
- •Aniridia
- •Sturge-Weber Syndrome
- •Neurofibromatosis
- •Secondary Glaucomas
- •Aphakic Glaucoma
- •Evaluating the Pediatric Glaucoma Patient
- •History
- •Visual Acuity
- •External Examination
- •Anterior Segment Examination
- •Tonometry
- •Central Corneal Thickness
- •Gonioscopy
- •Optic Nerve and Fundus Evaluation
- •Axial Length
- •Other Testing
- •Treatment Overview
- •Surgical Management
- •Medical Management
- •Prognosis and Follow-Up
- •7 Medical Management of Glaucoma
- •Medical Agents
- •Prostaglandin Analogues
- •β-Adrenergic Antagonists
- •Adrenergic Agonists
- •Carbonic Anhydrase Inhibitors
- •Parasympathomimetic Agents
- •Combined Medications
- •Hyperosmotic Agents
- •General Approach to Medical Treatment
- •Open-Angle Glaucoma
- •Angle-Closure Glaucoma
- •Administration of Ocular Medications
- •Use of Glaucoma Medications During Pregnancy or by Nursing Mothers
- •Use of Glaucoma Medications in Elderly Patients
- •Generic Medications
- •Compliance
- •8 Surgical Therapy for Glaucoma
- •Surgery for Open-Angle Glaucoma
- •Laser Trabeculoplasty
- •Incisional Surgery for Open-Angle Glaucomas
- •Combined Cataract and Filtering Surgery
- •Surgery for Angle-Closure Glaucoma
- •Laser Iridotomy
- •Laser Gonioplasty, or Peripheral Iridoplasty
- •Incisional Surgery for Angle Closure
- •Other Procedures to Lower IOP
- •Glaucoma Drainage Device Implantation
- •Ciliary Body Ablation Procedures
- •Nonpenetrating Glaucoma Surgery
- •Special Considerations in the Surgical Management of Elderly Patients
- •Basic Texts
- •Related Academy Materials
- •Requesting Continuing Medical Education Credit
Age
The depth and volume of the anterior chamber decrease with age. These changes predispose the eye to pupillary block; thus, the prevalence of angle-closure glaucoma with pupillary block increases with age. Acute angle-closure glaucoma is most common between the ages of 55 and 65 years, but it can occur in young adults and has been reported in children.
Refraction
Although PACG may occur hyperopia. The depth and predisposing them to PACG.
in eyes with any type of refractive error, it is typically associated with volume of the anterior chamber are reduced in hyperopic eyes,
Inheritance
Some of the anatomical features of the eye that predispose to pupillary block, such as a more anterior lens position and greater-than-average lens thickness, are inherited. Although generalizable estimates are lacking, a population-based survey in China suggests that a family history of glaucoma increases the risk of PACG sixfold.
Epstein DL, Allingham RR, Schuman JS, eds. Chandler and Grant’s Glaucoma. 4th ed. Baltimore: Williams & Wilkins; 1997:641– 646.
Ritch RM, Shields MB, Krupin T, eds. The Glaucomas. 2nd ed. St Louis: Mosby; 1996:753–765.
Genetics, Environmental Factors, and Glaucoma
The precise mechanism of inheritance of glaucoma is not clear. To date, many of the glaucomas appear to have an autosomal dominant inheritance pattern that may involve more than 1 gene (polygenic); have a late or variable age of onset; demonstrate incomplete penetrance (ie, the disease may not develop even when the causative gene has been inherited); and may be substantially influenced by environmental factors. See also BCSC Section 2, Fundamentals and Principles of Ophthalmology, Part III, Genetics. A positive family history is a risk factor for the development of POAG. The prevalence of glaucoma among siblings of glaucoma patients is approximately 10%.
The first gene described for POAG, GLC1A (also called the trabecular meshwork inducible glucocorticoid response/myocilin gene [TIGR/MYOC]), codes for the TIGR protein and is a trabecular meshwork glucocorticoid gene, located on chromosome 1. Mutations in GLC1A are present in 3% of the general open-angle glaucoma population. In the mid-1990s, the gene responsible for mutations in the TIGR protein was identified. Since then, several additional open-angle glaucoma genes have been mapped, and many more potential genes are being explored. The percentage of genes known to be associated with specific types of glaucoma is small, most likely because of the complex nature of the disease and because of the complicated interactions between multiple genetic loci and environmental factors (Table 1-4). Researchers are increasingly applying genome-wide scanning techniques to large cohorts of glaucoma subjects. These techniques may be useful for determining which regions of the genome are associated with glaucoma.
Kass MA, Becker B. Genetics of primary open-angle glaucoma. Sight Sav Rev. 1978;48:21–28.
Polansky JR, Fauss DJ, Chen P, et al. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica. 1997;211(3):126–139.
Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275(5300):668–670.
Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT. Genetic risk of primary open-angle glaucoma: population-based familial aggregation study. Arch Ophthalmol. 1998;116(12):1640–1645.
Table 1-4
Environmental Factors
Evidence that environmental factors can also play a role in the etiology of glaucoma arises from studies of twins and analysis of the season of birth of glaucoma patients. If glaucoma is genetically determined, then identical twins should theoretically share this trait more often than fraternal twins. In the Finnish Twin Cohort Study, 3 of 29 monozygotic twin pairs were concordant for POAG, compared with 1 of 79 dizygotic twin pairs. Although a higher percentage of monozygotic twins were concordant for glaucoma, most were not. These data suggest that although genetic factors contribute to the etiology of glaucoma, other factors, such as environmental influences, are important.
Genetic Testing
In the future, the management of some glaucoma patients will involve testing of multiple, and potentially interacting, genetic loci. Although there have been rapid advances in genetic techniques that allow this type of testing, advances in the study of genetic diseases require accurate categorization of individuals and families with specific phenotypes. By appropriately identifying families with strong histories of glaucoma, the practicing clinical ophthalmologist has an opportunity to provide important information to researchers in genetics. The cooperation of the clinician is therefore critical to the advancement of this crucial area of research.
The reader is encouraged to review the literature and to refer to websites such as GeneTests for information on genetic testing and its use in diagnosis, management, and genetic counseling (http://w ww.ncbi.nlm.nih.gov/sites/GeneTests/?db=GeneTests).
Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317(5843):1397–1400.
